Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 9.749.386.306.235.12

What is the latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS is 9.74 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20259.74
Mar20249.38
Mar20236.30
Mar20226.23
Mar20215.12

How is EV/EBIT of LINCOLN PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 9.74
3.84
Mar2024 9.38
48.89
Mar2023 6.3
1.12
Mar2022 6.23
21.68
Mar2021 5.12 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/EBIT ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,466.8 Cr 7.7% 20.3% 20.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,725.0 Cr -3.2% 10.5% 9.3% Stock Analytics
DIVIS LABORATORIES ₹182,775.0 Cr 0.8% 9.5% 4.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,764.0 Cr 2% 9.9% 35.4% Stock Analytics
CIPLA ₹113,007.0 Cr -1.9% 13.3% -6% Stock Analytics
DR REDDYS LABORATORIES ₹109,098.0 Cr -1.8% 7.4% 8.2% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

7.7%

20.3%

20.9%

SENSEX

0.2%

-4.9%

-8.4%


You may also like the below Video Courses